dextrothyroxine has been researched along with Symptom Cluster in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderon Candelario, RA; Kett, DH; Naidu, YV | 1 |
| Hartmeyer, GN; Martin-Iguacel, R; Pedersen, AA; Stensvold, CR | 1 |
| Cardenas-de la Garza, JA; Martinez, JD; Soria Orozco, M | 1 |
| Ashida, C; Funauchi, M; Kinoshita, K; Nozaki, Y | 1 |
| Amin, B; Jariwala, S; Patel, P; Rampur, L; Rosenstreich, DL | 1 |
| Carpenter, K; Kuriakose, K; Pettit, A; Wanjalla, C | 1 |
| Boussinesq, M; Kaiser, C; Pion, S | 1 |
| Bender, L; Foreyt, WJ; Hall, B | 1 |
| Seavers, A | 1 |
10 other study(ies) available for dextrothyroxine and Symptom Cluster
| Article | Year |
|---|---|
Strongyloides stercoralis hyperinfection syndrome: a known entity in an unknown provenance.
Topics: Albendazole; Animals; Humans; Ivermectin; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis; Syndrome; Vancomycin | 2022 |
Topics: Aged; Albendazole; Animals; Eosinophilia; Humans; Ivermectin; Larva; Male; Strongyloides stercoralis; Strongyloidiasis; Syndrome | 2022 |
Oral ivermectin for the treatment of red scrotum syndrome.
Topics: Erythema; Humans; Ivermectin; Male; Pain; Scrotum; Syndrome | 2022 |
Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Topics: Aged; Animals; Anthelmintics; Antiviral Agents; Coinfection; Cytomegalovirus; Cytomegalovirus Infections; Fatal Outcome; Female; Ganciclovir; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Ivermectin; Lupus Erythematosus, Systemic; Strongyloides stercoralis; Strongyloidiasis; Syndrome | 2020 |
DRESS syndrome with suspected Strongyloides infection in a patient treated for hepatitis C.
Topics: Animals; Antiparasitic Agents; Antiviral Agents; Drug Hypersensitivity; Eosinophilia; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Ivermectin; Male; Middle Aged; Oligopeptides; Prednisone; Recombinant Proteins; Ribavirin; Strongyloides; Strongyloidiasis; Syndrome | 2013 |
Case of Strongyloides hyperinfection syndrome.
Topics: Abdominal Pain; Adult; Animals; Antiparasitic Agents; Female; Humans; Immunocompromised Host; Ivermectin; Strongyloides stercoralis; Strongyloidiasis; Syndrome | 2017 |
Head nodding syndrome and river blindness: a parasitologic perspective.
Topics: Africa South of the Sahara; Animals; Antibodies, Helminth; Antiparasitic Agents; Cerebrospinal Fluid; Humans; Infant; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Spasms, Infantile; Syndrome | 2009 |
Nodding syndrome - South Sudan, 2011.
Topics: Adolescent; Animals; Anticonvulsants; Antiparasitic Agents; Case-Control Studies; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Disease Outbreaks; Head; Humans; Ivermectin; Movement Disorders; Nervous System Diseases; Odds Ratio; Onchocerca volvulus; Onchocerciasis; Risk Factors; Seizures; Sudan; Syndrome; United States | 2012 |
Evaluation of ivermectin for treatment of hair loss syndrome in black-tailed deer.
Topics: Alopecia; Animals; Animals, Wild; Anthelmintics; Deer; Dose-Response Relationship, Drug; Feces; Female; Injections, Subcutaneous; Ivermectin; Larva; Male; Nematode Infections; Phthiraptera; Syndrome | 2004 |
Cutaneous syndrome possibly caused by heartworm infestation in a dog.
Topics: Alopecia; Animals; Antiparasitic Agents; Dermatitis, Seborrheic; Diagnosis, Differential; Dirofilariasis; Dog Diseases; Dogs; Erythema; Female; Filaricides; Hyperpigmentation; Ivermectin; Mite Infestations; Pruritus; Skin Diseases, Parasitic; Syndrome | 1998 |